FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutics and represents a method of correcting aggressive behavior caused by chronic moderate stress, characterized by that correction of aggressive behavior caused by chronic moderate stress, is carried out using a composition of threo-3-phenylglutamic acid hydrochloride and succinic acid, wherein molar ratio of threo-3-phenylglutamic acid hydrochloride and succinic acid is 1:1.
EFFECT: technical result consists in the implementation of the aggressive behavior correction caused by chronic moderate stress, using the composition in the method according to the invention and low toxicity of the said composition.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
AGENT POSSESSIVE CARDIOPROTECTIVE ACTION UNDER STRESS STIMULATION | 2013 |
|
RU2531082C1 |
METHOD OF POTENTIAL PSYCOTROPIC AGENT CHARACTERISTICS DETECTION | 2006 |
|
RU2328038C1 |
PHARMACEUTICAL COMPOSITION FOR CORRECTING BEHAVIOR OF CATS AND DOGS IN STRESS SITUATIONS | 2019 |
|
RU2706700C1 |
AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
METHOD FOR INCREASING EFFECTIVENESS OF BASIC PSYCHOPHARMACOLOGICAL THERAPY OF MIXED ANXIETY AND DEPRESSIVE DISORDER | 2023 |
|
RU2817950C1 |
HYDROCHLORIDE OF 4-BENZYLPIPERAZIDE OF 3-METHYLBENFURANE-2-CARBOLIC ACID DISPLAYING PSYCHOTROPIC ACTIVITY | 0 |
|
SU1074094A1 |
PSYCHOTIC DISORDER SIMULATION METHOD | 2004 |
|
RU2366464C2 |
Authors
Dates
2020-02-21—Published
2019-06-19—Filed